Cargando…
Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
This publication discusses two compounds belonging to the psychoactive substances group which are studied in the context of depression treatment—psilocybin and esketamine. The former is a naturally occurring psychedelic. The latter was invented in the laboratory exactly 60 years ago. Although the su...
Autores principales: | Psiuk, Dominika, Nowak, Emilia Magdalena, Dycha, Natalia, Łopuszańska, Urszula, Kurzepa, Jacek, Samardakiewicz, Marzena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570062/ https://www.ncbi.nlm.nih.gov/pubmed/36232748 http://dx.doi.org/10.3390/ijms231911450 |
Ejemplares similares
-
The Potential Role of Serotonergic Hallucinogens in Depression Treatment
por: Psiuk, Dominika, et al.
Publicado: (2021) -
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
por: Heuschkel, Kristin, et al.
Publicado: (2020) -
Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021) -
Psychotherapy with Psilocybin for Depression: Systematic Review
por: Dawood Hristova, Jonathan Joseph, et al.
Publicado: (2023) -
Psilocybin-Assisted Compassion Focused Therapy for Depression
por: Pots, Wendy, et al.
Publicado: (2022)